54.00
0.00%
Close of 6 Nov 2026, in MXN
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Medica Sur SAB de CV
Its shares trade on BMV under the ticker MEDICAB.MX. It has been listed since 10 March 1994. In the fiscal year to 31 December 2025, it reported revenue of MXN 4.79bn and net income of MXN 540.2m. At that date it held total assets of MXN 4.78bn and shareholders' equity of MXN 2.52bn.
Medica Sur SA de CV engages in the provision of healthcare services. The company is headquartered in Tlalpan, Mexico, D.F.. The firm manages hospitals, emergency and diagnostic centers, medical laboratories, organ and blood banks, as well as an accommodation place. The company provides medical services within various specializations, such as anatomic pathology, cardiology, gynecology and obstetrics, neonatology, neurophysiology, odontology, oncology, ophthalmology, orthopedics, otolaryngology, pediatrics, radiology and imaging, as well as radiosurgery. In addition, the Company offers medical tourism services and distributes drugs. The company forms a part of Mayo Clinic Care Network. The firm operates through a range of subsidiaries, such as Corporacion de Atencion Medica SA de CV, El Portal Medico SA de CV, Servicios de Administracion Hospitalaria SA de CV and Telemed SA de CV. The firm is owned by Neuco SA de CV.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 10 Mar 1994
- Employees
- 3,322
- Website
- medicasur.com.mx ↗
Leadership
Pay as last reported
- Dr. Misael Uribe EsquivelExecutive Chairman of the Board, Proprietary Director
- Dr. Octavio Gonzalez ChonChief Executive Officer, Executive Director, since 2025
- Mr. Juan Ahedo RozadaChief Financial & Administrative Officer
- Dr. Jose Manuel Correa RoveloChief Operating Officer, Executive Director
- Mr. Moises Francisco Jose Ramos GonzalezGeneral Counsel, Non-Member Secretary of the Board of Directors
- Dr. Martha Helena Ramos OstosExecutive Proprietary Director, Director - Clinical Diagnostics and Imaging, since 2017
- Ms. Adriana Lizet Aceves PadillaExecutive Proprietary Director, since 2022
- Mr. Jaime Manalich MuxiExecutive Proprietary Director
- Dr. Panagiota PanopoulouExecutive Proprietary Director, since 2022
- Dr. Salvador Oscar Rivero BoschertExecutive Proprietary Director
- Ms. Martha Helena Uribe RamosExecutive Proprietary Director
- Mr. Alejandro Guerrero ZendejasDirector - Sales
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 42
- Environment
- 50
- Social
- 43
- Governance
- 33
- Direct emissions (scope 1)
- 1,420 t
- Energy emissions (scope 2)
- 5,659.5 t
- Women in the workforce
- 60%
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Medica Sur SAB de CV possesses several strengths:
Weaknesses
- Despite its strengths, Medica Sur SAB de CV faces certain weaknesses:
Opportunities
- Medica Sur SAB de CV can capitalize on the following opportunities:
Threats
- However, Medica Sur SAB de CV should be cautious of the following threats:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.